Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes

Clinical Dysmorphology, Chromosomal Aneuploidies, and Microdeletion Syndromes

Dysmorphology is the study of human congenital structural malformations and abnormal physical development. A rigorous, head-to-toe morphological evaluation of the infant allows the paediatrician to differentiate normal familial variants from pathological syndromic entities. Recognizing whether structural anomalies represent isolated events, sequential mechanical cascades, or generalized chromosomal or microdeletion syndromes directly dictates life-saving diagnostic investigations, surgical referrals, and long-term neurodevelopmental prognostication.

---

Diagnostic Approach to the Dysmorphic Child

The diagnostic approach begins by differentiating major structural malformations from minor dysmorphic variants, and categorizing the underlying embryological defect into its precise pathogenetic mechanism.

                                  [Structural Anomalies]
                                             |
                 +---------------------------+---------------------------+
                 |                                                       |
          [Major Anomalies]                                       [Minor Anomalies]
    - Medical/surgical significance                         - Present in <5% of population
    - Requires clinical intervention                        - No functional impairment alone
    - E.g., VSD, cleft palate, spina bifida                  - E.g., single palmar crease, low-set ears
                                                                         |
                                                                         v
                                                               [Diagnostic Red Flag]
                                                               >=3 Minor Anomalies: >90% risk
                                                               of occult major defect/syndrome

Major vs. Minor Congenital Anomalies

1. Major Anomalies:
   • Structural defects that have significant medical, surgical, or major cosmetic consequences for the individual.
   • Examples include congenital heart disease (e.g., ventricular septal defect, coarctation of the aorta), neural tube defects (myelomeningocele), omphalocele, gastroschisis, microcephaly, and orofacial clefts (cleft lip/palate).
   • Population prevalence: approximately $2\%$ to $3\%$ of all liveborn infants.
2. Minor Anomalies:
   • Subtle physical features or anatomical variations present in less than $5\%$ of the general population that do not, in isolation, cause functional medical or cosmetic impairment.
   • Examples include a single transverse palmar crease (simian crease), clinodactyly (incurvature of the 5th finger), preauricular pits or skin tags, low-set or posteriorly rotated ears, epicanthic folds, up-slanting or down-slanting palpebral fissures, and a widened sandal gap between the 1st and 2nd toes.
   • The Clinical Rule of Three: An isolated minor anomaly is present in approximately $15\%$ of normal newborns and carries negligible pathological risk. However, the presence of two minor anomalies increases the risk of an underlying major malformation to $10\%$, whereas the discovery of three or more minor anomalies is associated with a $>90\%$ probability of an occult major internal malformation (e.g., congenital cardiac or renal anomaly) or an underlying genetic syndrome, mandating comprehensive genetic and imaging investigations.

Categories of Morphogenetic Errors

Embryological structural errors are classified into four distinct pathogenetic categories based on the nature of the primary tissue disruption:

                              [Pathogenetic Mechanisms]
                                          |
     +------------------+-----------------+------------------+------------------+
     |                  |                                    |                  |
[Malformation]     [Deformation]                        [Disruption]        [Dysplasia]
- Intrinsic error   - Extrinsic mechanical               - Extrinsic breakdown - Abnormal cellular
  in development      force on normal tissue              of normal tissue     organization
- Cause-specific    - Low recurrence                     - Low recurrence    - Progressive tissue
- E.g., AVSD, Cleft - E.g., Oligohydramnios / Clubfoot   - E.g., Amniotic band disorder (Skeletal)

1. Malformation:
   • A primary structural defect of an organ, part of an organ, or larger body region resulting from an intrinsic abnormal developmental process (genetic programming error, localized blastogenesis failure).
   • Characteristics: Occurs during embryonic organogenesis (first 8–10 weeks of gestation); may require intervention, although some defects such as small VSDs close spontaneously; recurrence risk depends on the underlying cause.
   • Examples: Ventricular septal defect, cleft lip and palate, neural tube defects, syndactyly.
2. Deformation:
   • An abnormal form, shape, or position of a body part caused by extrinsic mechanical forces acting upon structurally normal tissue.
   • Characteristics: Occurs late in gestation (second or third trimester) after embryonic organogenesis is complete; the skeleton or tissue is intrinsically normal; frequently reversible postnatally with conservative positioning, physical therapy, or casting; recurrence risk in future pregnancies is typically negligible (unless the maternal mechanical cause persists).
   • Examples: Congenital talipes equinovarus (clubfoot) or facial asymmetry secondary to severe uterine crowding, multiple gestation, bicornuate uterus, or oligohydramnios.
3. Disruption:
   • A structural defect resulting from the extrinsic destructive breakdown or interference with an originally normal developing organ or structure.
   • Characteristics: Normal tissue is mechanically destroyed, amputated, or infarcted during fetal development; usually sporadic with near-zero recurrence risk in subsequent pregnancies.
   • Examples: Amniotic Band Syndrome (early rupture of amnion produces fibrous strands that encircle and mechanically amputate fetal digits or limbs); intestinal atresia secondary to localized in utero mesenteric vascular thrombosis.
4. Dysplasia:
   • An abnormal organization of cells into tissues and the cellular morphological consequences throughout that tissue type.
   • Characteristics: Caused by genetic defects in cellular signaling, extracellular matrix, or enzymatic pathways; persists and progresses throughout life as the tissue grows.
   • Examples: Skeletal dysplasias (e.g., Achondroplasia due to FGFR3 mutations affecting endochondral ossification; Osteogenesis Imperfecta due to type I collagen defects); ectodermal dysplasia.

Sequences, Syndromes, and Associations

• Sequence: A cascade of secondary structural anomalies triggered by a single localized primary mechanical or developmental defect. Classic paradigms:
  • Potter Sequence: Primary bilateral renal agenesis (or chronic obstructive uropathy) $\rightarrow$ severe oligohydramnios (lack of fetal urine production) $\rightarrow$ uterine compression of the fetus $\rightarrow$ compressed facial features ("Potter facies": flattened nose, recessed chin, low-set ears), limb contractures/clubfoot, and fatal pulmonary hypoplasia (lack of amniotic fluid inhalation prevents alveolar branching).
  • Pierre Robin Sequence: Primary micrognathia (mandibular hypoplasia) occurring before the 9th week of gestation $\rightarrow$ posterior displacement of the tongue (glossoptosis), causing oropharyngeal obstruction $\rightarrow$ mechanical prevention of normal horizontal palatal shelf fusion $\rightarrow$ secondary wide, U-shaped cleft palate and upper airway obstruction.
• Syndrome: A recognizable, non-random pattern of multiple anomalies pathogenetically related to a single recognized underlying etiology (chromosomal aneuploidy, microdeletion, or single-gene defect; e.g., Down syndrome, 22q11.2 deletion syndrome).
• Association: A statistically non-random co-occurrence of multiple congenital anomalies that occur together more frequently than expected by chance alone, but for which no single unifying genetic or pathogenetic etiology has been elucidated.
  • VACTERL Association: Vertebral anomalies, Anal atresia, Cardiac malformations (especially VSD), Tracheo-Esophageal fistula with esophageal atresia, Renal anomalies, and Limb abnormalities (radial ray hypoplasia). Diagnosis requires at least three features; karyotype and microarray are typically normal.
  • CHARGE Syndrome: Formerly an association, now recognized as a distinct monogenic syndrome caused by CHD7 mutations: Coloboma (iris/retina), Heart defects (conotruncal), Atresia of choanae, Retardation of growth and development, Genital hypoplasia, and Ear abnormalities/sensorineural deafness.

---

Autosomal Chromosomal Aneuploidies

Autosomal trisomies represent numerical chromosomal aberrations arising primarily from meiotic nondisjunction during parental gametogenesis.

1. Down Syndrome (Trisomy 21)

Down syndrome is the most prevalent chromosomal aneuploidy, affecting approximately 1 in 700 to 1 in 800 live births.

Cytogenetics

• Free Trisomy 21 ($95\%$): Caused by meiotic nondisjunction ($47,XX,+21$ or $47,XY,+21$). Most nondisjunction events are maternal in origin and can arise in meiosis I or II; the chance of trisomy 21 increases with maternal age.
• Robertsonian Translocation ($4\%$): The long arm of chromosome 21 is translocated onto another acrocentric chromosome, most commonly chromosome 14 [$rob(14;21)$] or chromosome 21 [$rob(21;21)$]. In approximately one-third of $rob(14;21)$ cases, a parent is a balanced carrier; parental karyotyping is needed ($45,XX,\text{rob}(14;21)$). When a mother carries a balanced $rob(14;21)$ translocation, the theoretical recurrence risk is $33\%$ and empirical risk is $10–15\%$; if the father is the carrier, the NHS Genomics counselling range is $2–5\%$. If a parent carries a balanced homologous $rob(21;21)$ translocation, the recurrence risk is 100% (all viable pregnancies will have translocation Down syndrome).
• Mosaicism ($1\%$): Post-zygotic mitotic nondisjunction producing two cell lines ($46,XX/47,XX,+21$). Phenotype is often milder depending on the proportion and tissue distribution of the trisomic cell line.

Clinical Features

• Neonatal Signs: Marked central hypotonia with poor Moro reflex, hyperflexibility of large joints, excessive nuchal skin folds, flattened facial profile, and flat occiput.
• Craniofacial: Up-slanting palpebral fissures, prominent epicanthic folds, Brushfield spots (speckled rings of hypoplasia on the iris margin), small dysplastic ears, flat nasal bridge, protruding tongue due to small oral cavity.
• Extremities: Single transverse palmar crease (simian crease, $50\%$), clinodactyly of the fifth digit with hypoplastic middle phalanx, widened sandal gap between the first and second toes.

Systematic Paediatric Health Surveillance

• Congenital Heart Defects ($40–50\%$): Mandatory screening transthoracic echocardiogram in all neonates. Prototypic lesion is a Complete Atrioventricular Septal Defect (AVSD / AV canal defect), followed by ventricular septal defects (VSD), atrial septal defects (ASD), and patent ductus arteriosus (PDA).
• Gastrointestinal ($10–12\%$): Duodenal atresia (classic "double bubble" sign on abdominal radiograph, bilious vomiting in the first 24 hours), annular pancreas, Hirschsprung disease, tracheoesophageal fistula.
• Endocrine Surveillance: Congenital and acquired primary hypothyroidism (elevated TSH, low free T4); review neonatal thyroid screening; AAP advises additional TSH if the newborn programme measures T4 alone, then TSH at 6 and 12 months and annually. Review for coeliac symptoms and follow national testing guidance; UK practice uses a low threshold for serology rather than universal screening at 2–3 years.
• Musculoskeletal and Neurology: Atlantoaxial Instability (AAI) occurs in $10–15\%$ due to transverse atlantoaxial ligament laxity. Annual clinical screening for signs of cervical spinal cord compression (hyperreflexia, clonus, gait deterioration, torticollis, bowel/bladder dysfunction); routine screening cervical radiographs in asymptomatic children are no longer universally mandated, but symptomatic surveillance before high-risk sports or general anesthesia is vital.
• Hematology and Oncology: Transient Myeloproliferative Disorder (TMD / transient abnormal myelopoiesis) occurs in $5–10\%$ of neonates harboring GATA1 somatic mutations, presenting with marked peripheral blast counts; usually resolves spontaneously within 3 months, but $20–30\%$ subsequently develop Acute Megakaryoblastic Leukemia (AML-M7) by age 3–4. Overall lifetime risk of acute lymphoblastic leukemia (ALL) and AML is elevated 10- to 20-fold.

2. Edwards Syndrome (Trisomy 18)

• Prevalence and Prognosis: Incidence 1 in 6,000 live births; female predominance ($3:1$); $>90\%$ of affected infants die within the first year of life due to cardiac failure or central apnea.
• Hallmark Phenotype: Severe intrauterine growth restriction (IUGR) with marked post-natal failure to thrive; prominent occiput, narrow bifrontal diameter, micrognathia, low-set malformed "faun-like" ears; short sternum with narrow pelvis.
• Extremity Hallmarks: Clenched hands with overlapping digits (index finger overlapping the 3rd finger, and 5th finger overlapping the 4th finger; absent distal flexion creases); rocker-bottom feet (prominent calcaneus with convex, rounded plantar surface); hypoplastic nails; hypoplastic thumbs.
• Internal Defects: Congenital heart defects in $>90\%$ (large VSD, PDA, polyvalvular dysplasia); omphalocele, diaphragmatic hernia, horseshoe kidney, choroid plexus cysts on antenatal ultrasound.

3. Patau Syndrome (Trisomy 13)

• Prevalence and Prognosis: Incidence 1 in 10,000 to 1 in 20,000 live births; severe lethality with median survival $<2$ weeks; $>90\%$ mortality in the first year.
• Hallmark Phenotype:
  • Defective Midline Forebrain Cleavage (Holoprosencephaly Spectrum): Failure of prosencephalon division into cerebral hemispheres, ranging from alobar holoprosencephaly to cyclopia, ethmocephaly, or single central incisor.
  • Midface and Cranial Anomalies: Severe bilateral cleft lip and cleft palate; microphthalmia, anophthalmia, or hypotelorism; cutis aplasia (congenital punched-out, localized absence of scalp skin at the vertex).
  • Extremity Anomalies: Postaxial polydactyly of hands and feet (extra digits on the ulnar/fibular border); hyperconvex fingernails; clenched fists.
  • Internal Defects: Severe congenital heart disease ($>80\%$: VSD, ASD, PDA, dextrocardia); cystic dysplastic or polycystic kidneys; cryptorchidism, bicornuate uterus; severe profound intellectual disability and intractable neonatal seizures.

---

Sex Chromosome Aneuploidies

Numerical abnormalities of sex chromosomes are among the most common cytogenetic aberrations, typically presenting with less severe physical and intellectual deficits than autosomal aneuploidies due to X-inactivation and the low gene content of the Y chromosome.

1. Turner Syndrome (45,X)

• Cytogenetics: Complete monosomy X ($45,X$) accounts for approximately $50\%$ of cases, resulting from parental meiotic nondisjunction (loss of the paternal sex chromosome in $70–80\%$). The remaining $50\%$ exhibit chromosomal mosaicism ($45,X/46,XX$, $45,X/46,XY$) or structural X abnormalities (e.g., isochromosome Xq [$46,X,i(Xq)$], ring X chromosome).
• Clinical Features:
  • Neonatal: Congenital lymphedema of the dorsum of the hands and feet; redundant nuchal skin folds (cystic hygroma on fetal ultrasound).
  • Somatic Features: Short stature (present in $>95\%$, mediated by haploinsufficiency of the SHOX gene on the pseudoautosomal region PAR1); webbed neck (pterygium colli) with low posterior hairline; broad shield-shaped chest with widely spaced, hypoplastic nipples; cubitus valgus (increased carrying angle of elbows); multiple pigmented nevi; high-arched palate.
  • Gonadal and Endocrine: Ovarian dysgenesis (streak gonads) leading to primary ovarian insufficiency, elevated gonadotropins (hypergonadotropic hypogonadism: high FSH and LH), often absent or incomplete puberty, primary amenorrhea and infertility; some girls retain ovarian function, so discuss fertility individually. Autoimmune Hashimoto thyroiditis ($30\%$) and celiac disease.
  • Cardiovascular: Critical source of early morbidity: Bicuspid aortic valve ($30\%$) and Coarctation of the aorta ($10–15\%$); progressive aortic root dilation and fatal aortic dissection.
  • Renal: Horseshoe kidney ($15\%$), duplicated collecting systems.
  • Cognitive: Normal overall intelligence; selective non-verbal, spatial perception, and executive functioning deficits.
• Management Guidelines: Baseline cardiology evaluation with transthoracic echocardiogram and cardiac MRI; renal ultrasound; recombinant human growth hormone (rhGH) initiated in childhood to optimize final adult height; transdermal estrogen replacement therapy initiated around age 11–12 for pubertal induction, followed by cyclic progesterone. Y-Chromosome Material: Gonadoblastoma/dysgerminoma risk warrants specialist counselling. The 2024 international Turner guideline recommends individualized decisions about gonadectomy and its timing, balancing tumour risk against gonadal function and potential fertility.

2. Klinefelter Syndrome (47,XXY)

• Cytogenetics: $47,XXY$ karyotype in $80–85\%$, arising from nondisjunction during maternal ($50\%$) or paternal ($50\%$) meiosis. Variants include $48,XXXY$ and mosaicism ($46,XY/47,XXY$).
• Clinical Presentation: Frequently undetected until adolescence or adult fertility workups:
  • Prepubertal: Mild expressive language delays, motor clumsiness, tall stature with long lower extremities.
  • Postpubertal: Tall stature with eunuchoid proportions (lower body segment greater than upper body segment, arm span exceeding height); bilateral gynecomastia ($40–50\%$, carrying a 20- to 50-fold increased risk of male breast cancer); sparse body, facial, and pubic hair; female fat distribution.
  • Endocrine & Gonadal: Small, firm testes (micro-orchidism, testicular volume $<4\text{ mL}$) secondary to hyalinization and fibrosis of seminiferous tubules; Leydig cell dysfunction causing primary hypogonadism with hypergonadotropic hypogonadism (elevated serum FSH and LH, subnormal testosterone); azoospermia and infertility in most patients; selected patients can father children using surgically retrieved sperm and assisted reproduction.
  • Neurocognitive: Normal global intelligence, but high incidence of dyslexia, auditory processing deficits, and executive dysfunction.
• Management: Monitor puberty and testosterone/LH. Under EAA/ESE guidance, offer testosterone for delayed puberty or symptomatic biochemical hypogonadism after discussing fertility; compensated adolescents without symptoms do not automatically require treatment.

---

Microdeletion and Imprint Syndromes

Submicroscopic microdeletions involve contiguous gene deletions mediated by non-allelic homologous recombination between low-copy repeats (LCRs).

                             [Key Microdeletion Syndromes]
                                          |
                 +------------------------+------------------------+
                 |                                                 |
       [22q11.2 Deletion]                                [7q11.23 Deletion]
     - CATCH-22 Complex                                - Williams Syndrome
     - Conotruncal cardiac (ToF, Truncus)              - Supravalvular aortic stenosis
     - Thymic hypoplasia (T-cell defect)               - Cocktail party personality
     - Hypocalcemia (parathyroid defect)               - Infantile hypercalcemia
     - Cleft palate / VPI                              - Elastin (ELN) gene loss

1. 22q11.2 Deletion Syndrome (DiGeorge / Velocardiofacial Syndrome)

• Etiology: 3-megabase heterozygous microdeletion on chromosome 22q11.2, encompassing the TBX1 transcription factor gene responsible for third and fourth pharyngeal pouch and branchial arch development.
• Clinical Spectrum (CATCH-22 Mnemonic):
  • C - Cardiac Defects ($75–80\%$): Conotruncal cardiovascular malformations: Tetralogy of Fallot (ToF), Truncus Arteriosus, Interrupted Aortic Arch type B, aberrant right subclavian artery, perimembranous VSD.
  • A - Abnormal Facies: Tubular nose with bulbous nasal tip, hypoplastic alae nasi, hooded eyelids, hypertelorism, micrognathia, small ears with overfolded helices.
  • T - Thymic Hypoplasia / Aplasia: Defective cellular immunity manifesting as T-cell lymphopenia with recurrent viral, fungal, and opportunistic infections; severe complete DiGeorge ($<1\%$) requires urgent thymic transplantation.
  • C - Cleft Palate / Craniofacial: Submucous cleft palate, bifid uvula, and velopharyngeal incompetence (VPI) resulting in characteristic hypernasal speech and nasal regurgitation of fluids in infancy.
  • H - Hypocalcemia ($60\%$): Caused by parathyroid hypoplasia, presenting in the neonatal period with jitteriness, carpopedal tetany, or refractory neonatal seizures; often remits after infancy but can recur during physiological stress.
  • Neuropsychiatric Morbidity: High prevalence of ADHD, autism spectrum disorder, and a striking $25–30\%$ risk of developing schizophrenia or schizoaffective disorder in late adolescence and adulthood.

2. Williams Syndrome (Williams-Beuren Syndrome)

• Etiology: Heterozygous 1.5- to 1.8-megabase contiguous microdeletion on chromosome 7q11.23, encompassing approximately 28 genes including the Elastin gene (ELN).
• Clinical Hallmarks:
  • Craniofacial ("Elfin Facies"): Periorbital fullness, stellate/lacy iris pattern, short upturned nose with depressed bridge, long smooth philtrum, wide mouth with full lips, and widely spaced teeth.
  • Cardiovascular: Arteriopathy mediated by elastin deficiency: Supravalvular Aortic Stenosis (SVAS) is the classic pathognomonic lesion; peripheral pulmonary artery stenosis, coarctation, renal artery stenosis (causing secondary renovascular hypertension).
  • Metabolic: Infantile hypercalcemia (symptomatic irritability, vomiting, nephrocalcinosis) due to abnormal vitamin D metabolism; resolves in late childhood.
  • Neurobehavioral Profile: Unique cognitive dissociation: highly articulate expressive language, loquacious speech, rich vocabulary, and passionate musical affinity, paired with profound visuospatial constructional deficits and moderate intellectual disability. Distinctive "cocktail party" personality: excessive friendliness, lack of stranger anxiety, social disinhibition, paired with generalized anxiety.

3. Noonan Syndrome (A Prototypic RASopathy)

• Etiology: Autosomal dominant condition caused by hyperactivating germline mutations in genes of the RAS-MAPK signal transduction pathway (PTPN11 in $50\%$, SOS1, RAF1, RIT1, KRAS).
• Clinical Phenotype:
  • Craniofacial: Hypertelorism, down-slanting palpebral fissures, ptosis, low-set posteriorly rotated ears, broad forehead.
  • Somatic: Short stature (severe post-natal growth failure), webbed neck (pterygium colli), low posterior hairline, pectus deformities (pectus carinatum superiorly and pectus excavatum inferiorly).
  • Cardiovascular: Pulmonary Valve Stenosis with dysplastic pulmonary valve leaflets ($50–60\%$) and Hypertrophic Cardiomyopathy (HCM, $20\%$).
  • Hematology: Bleeding diathesis in $30–50\%$ due to factor deficiencies (factor XI, XII, or VIII) and platelet dysfunction; elevated risk of juvenile myelomonocytic leukemia (JMML).
  • Differentiating from Turner Syndrome: Normal karyotype (46,XX or 46,XY); occurs in both sexes; associated with right-sided heart lesions (pulmonary stenosis) rather than left-sided lesions (coarctation/bicuspid aorta); fertile females.

---

Teratogenic Syndromes: Fetal Alcohol Spectrum Disorder (FASD)

Teratogens are exogenous chemical, physical, or infectious agents that cause permanent structural or functional defects following in utero maternal exposure during critical developmental windows.

Fetal Alcohol Syndrome (FAS)

Ethanol is a direct embryotoxic teratogen that crosses the placenta unimpeded, inducing apoptotic neuronal death, inhibiting cell adhesion molecule L1, and generating oxidative stress during embryogenesis.

• Diagnostic Triad for FAS:
  1. Characteristic Craniofacial Dysmorphology:
     • Smooth (flattened) philtrum (grades 4–5 on the standardized Lip-Philtrum Guide).
     • Thin upper lip (thin vermilion border).
     • Short palpebral fissures ($\le 10\text{th}$ percentile for age).
     • Additional facial features: Flat midface, low nasal bridge, epicanthic folds, minor ear abnormalities.
  2. Growth Deficiency:
     • Prenatal and/or postnatal growth impairment: height or weight $\le 10\text{th}$ percentile documented at any stage of life.
  3. Central Nervous System / Neurodevelopmental Damage:
     • Structural: Microcephaly (head circumference $\le 10\text{th}$ percentile), agenesis of corpus callosum, cerebellar hypoplasia.
     • Functional: Global developmental delay, intellectual impairment, executive functioning deficits, severe impulsivity, ADHD, and impaired adaptive socialization.